“X-ray – the world’s oldest form of medical imaging – just got a whole lot smarter, and soon, the rest of our offerings will too,” says Kieran Murphy, President & CEO, GE Healthcare. “GE Healthcare is leading the way in the creation of AI applications for diagnostic imaging and taking what was once a promise... Read more
MILFORD, Mass.–(BUSINESS WIRE)–Sep. 11, 2019– Waters Corporation (NYSE: WAT) today announced Mark T. Beaudouin is retiring as Senior Vice President, General Counsel and Corporate Secretary after 16 years leading the Company’s legal team. Current Vice President, Deputy General Counsel and Assistant Secretary, Keeley A. Aleman, will be promoted to Senior Vice President, General Counsel and Corporate Secretary, and a member... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Sep. 10, 2019– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $850 million aggregate principal amount of 3.300% Senior Notes due 2029 at an issue price of 99.670% of the principal amount. The issuance of the notes is... Read more
Cheshire, UK – 03 September 2019 – BioCity, the pioneering life science incubator and business collective has today announced investment in Maxwellia. The world’s first prescription (Rx) to Over the Counter (OTC) switch incubator, Maxwellia’s novel approach converts prescription drugs into versions that can be purchased without prescription from pharmacies and supermarkets; a process known as... Read more
Venlo, The Netherlands, September 10, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has decided to integrate its global sales resources into its Business Areas (Life Sciences, Molecular Diagnostics and Bioinformatics). This transition is expected to allow the Business Areas to oversee the full value chain from innovation to... Read more
Basel, 10 September 2019 Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS Blood neurofilament light chain (NfL) levels were significantly lowered following OCREVUS treatment in analyses of Phase III studies in RMS and PPMS New data show NfL may be a biomarker for predicting future... Read more
9 September 2019, Oncimmune Holdings plc (AIM: ONC.L), a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT® Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.... Read more
Having already received the SelectScience Scientists’ Choice Award, the inverted Raman microscope alpha300 Ri has also now been awarded the Bronze Seal of Quality after receiving many positive reviews from customers. SelectScience® Seals of Quality recognize products that have consistently received the best reviews from scientists around the world and are designed to further assist scientists... Read more
Agilent Technologies Announces Proposed Offering of Senior Notes SANTA CLARA, Calif., September 05, 2019 Agilent Technologies Inc. (NYSE:A) today announced it is offering, subject to market and other conditions, a series of senior notes under an automatic shelf registration statement on file with the Securities and Exchange Commission. Actual terms of the notes, including interest... Read more
04 SEP 2019 | DARMSTADT, GERMANY Belgian chemist wins prestigious science award worth € 15,000 Recognition of young researchers who develop new methods in chemical analysis Merck KGaA, Darmstadt, Germany, a leading science and technology company, presented Professor David Alsteens (33), Catholic University of Louvain (UCLovain), Louvain-la-Neuve, Belgium with the 2019 Heinrich Emanuel Merck Award for Analytical Science.... Read more